NCT05471440View on ClinicalTrials.gov

SWITCH ON: Analysing the Immunogenicity of Additional Booster Vaccinations in HCW

NAUnknownINTERVENTIONAL
Enrollment

431

Participants

Timeline

Start Date

August 20, 2022

Primary Completion Date

September 15, 2022

Study Completion Date

August 30, 2023

Conditions
Covid-19 Vaccination
Interventions
DRUG

Direct boost mRNA

Participants will be boosted with a covid-19 vaccin after priming with mRNA

DRUG

Direct boost adeno

Participants will be boosted with a covid-19 vaccin after priming with adeno

DRUG

Post-poned boost mRNA

Participants will be boosted with a covid-19 vaccin after priming with mRNA

DRUG

Post-poned boost adeno

Participants will be boosted with a covid-19 vaccin after priming with adeno

Trial Locations (4)

1105AZ

AmsterdamUMC, Amsterdam

9713GZ

UMCG, Groningen

2333ZA

LUMC, Leiden

3015 GD

Erasmus MC, Rotterdam

Sponsors
All Listed Sponsors
collaborator

ZonMw: The Netherlands Organisation for Health Research and Development

OTHER

collaborator

Leiden University Medical Center

OTHER

collaborator

University Medical Center Groningen

OTHER

collaborator

Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)

OTHER

lead

Erasmus Medical Center

OTHER